Kidney biomarkers such as NGAL, KIM-1, IL-18, L-FABP (liver-type fatty acid–binding protein), and CysC possess the capacity to fill several knowledge gaps about AKI, including early detection, differential diagnosis, and prognosis. The gene discussed is IL18; the disease is acute kidney injury.